speb/financial-data huggingface dataset:
Financial ratios for EUROTEXIND.NS — annual report dated 2025-03-31
Total revenue: 135199.90647650222
Gross profit: 133680.14963759645
Operating income: -776209.9602525134
Net income: -203682.4877250409
Capital expenditures: 358604.16179565113
Operating cash flow: -193009.11854103341
Depreciation & amortization: 292763.61935936403
Net tangible assets: -3362052.8407762446
Owner earnings: -269523.03016132803
Buffett classification: The Gruesome
Stock price: 0.14855875831485588
Shares outstanding: 8749865
Book value: -3362052.840776245
Market cap (USD): 1299869.0798226164
Debt to equity: -1.1596369832052573
Current ratio: 0.30236268190684124
Quick ratio: 0.27414253951181144
Interest coverage ratio: -2.847701149425287
COGS to revenue (%): 1.1240812797233029
SG&A to revenue (%): 49.338521400778205
Free cash flow (dilution-adjusted): -195440.72948328266
Buyback yield (%): 0
Retained earnings: -9564648.117839606
Inventory turnover: 0.009244115764772808
Receivables turnover: 5.455188679245284
Capitalized R&D asset: 0
FCF margin (%): -144.55685257241677
Revenue growth (%): 79.09960605362224
Rule of 40 score: -65.45724651879453
Financial ratios for EUROTEXIND.NS — quarterly report dated 2025-06-30
Total revenue: 5183.711677978002
Gross profit: 5183.711677978002
Operating income: -138602.85513690618
Net income: -101848.81816054296
Capital expenditures: 0
Depreciation & amortization: 21881.58202667915
Owner earnings: -79967.2361338638
Buffett classification: The Gruesome
Stock price: 0.19260472735782824
P/E ratio: 562.4259469237147
Shares outstanding: 8749865
Market cap (USD): 1685265.3627428038
Interest coverage ratio: -1.8075690523424388
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -91.20557919606826
Rule of 40 score: -91.20557919606826
Financial ratios for EUROTEXIND.NS — quarterly report dated 2025-09-30
Total revenue: 4577.226606538895
Gross profit: 4577.226606538895
Operating income: -135569.33483652762
Net income: 229819.6166854566
Capital expenditures: 0
Depreciation & amortization: 19695.603156708003
Net tangible assets: -3094701.2401352874
Owner earnings: 249515.2198421646
Return on net tangible assets (%): -8.062659380692168
Buffett classification: The Gruesome
Stock price: 0.17857948139797067
P/E ratio: 6.711506493422082
Shares outstanding: 8749865
Book value: -3094701.2401352874
Market cap (USD): 1562546.3540022545
Debt to equity: -1.3010018214936248
Current ratio: 0.28873876527417786
Quick ratio: 0.2591034941259636
Effective tax rate (%): -12.562120375483158
Interest coverage ratio: -1.9178628389154706
COGS to revenue (%): 0
Buyback yield (%): 0
Inventory turnover: 0
Receivables turnover: 0.5152284263959391
Capitalized R&D asset: 0
Revenue growth (%): -11.699822619680827
Rule of 40 score: -11.699822619680827
Financial ratios for EUROTEXIND.NS — quarterly report dated 2025-12-31
Total revenue: 1982.8450484571683
Gross profit: 1982.8450484571683
Operating income: -141584.04812298095
Net income: -115227.8043889941
Capital expenditures: 0
Depreciation & amortization: 19004.12164420185
Owner earnings: -96223.68274479226
Buffett classification: The Gruesome
Stock price: 0.16631391333407597
P/E ratio: 7.015308562374869
Shares outstanding: 8749865
Market cap (USD): 1455224.2892948645
Interest coverage ratio: -2.0670027646771834
COGS to revenue (%): 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -56.68020793148993
Rule of 40 score: -56.68020793148993
Financial ratios for EVR.AX — annual report dated 2021-06-30
Operating income: -2301287.2180451127
Net income: -2261231.578947368
Capital expenditures: 342885.71428571426
Depreciation & amortization: 2723.308270676692
Net tangible assets: 3106745.112781955
Owner earnings: -2601393.9849624056
Return on net tangible assets (%): -83.73374353304996
Buffett classification: The Gruesome
Stock price: 0.015037593984962405
Shares outstanding: 3040003147
Book value: 3120230.8270676685
P/B ratio: 14.650945898305674
Market cap (USD): 45714333.03759398
Debt to equity: 0
Current ratio: 4.402808985568253
Quick ratio: 4.402808985568253
Free cash flow (dilution-adjusted): -1926184.2105263157
Buyback yield (%): 0.30660823523154074
Retained earnings: -30606957.89473684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -73.75374918040333
Rule of 40 score: 0
Financial ratios for EVR.AX — annual report dated 2022-06-30
Operating income: -2335315.8620689656
Net income: -1614832.4137931035
Capital expenditures: 4941.379310344828
Depreciation & amortization: 2949.655172413793
Net tangible assets: 6763169.655172414
Owner earnings: -1616824.1379310347
Return on net tangible assets (%): -23.90630755055067
Buffett classification: The Gruesome
Stock price: 0.013793103448275864
Shares outstanding: 3040003147
Book value: 6807373.793103448
P/B ratio: 6.15965556822156
Market cap (USD): 41931077.88965518
Debt to equity: 0
Current ratio: 11.401355279380136
Quick ratio: 11.401355279380136
Free cash flow (dilution-adjusted): -2776121.379310345
Buyback yield (%): 0.3450111560032539
Retained earnings: -29590869.655172415
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -34.280816748501266
Rule of 40 score: 0
Financial ratios for EVR.AX — annual report dated 2023-06-30
Operating income: -2923882.119205298
Net income: -3459318.5430463576
Capital expenditures: 224298.67549668875
Depreciation & amortization: 1982.1192052980132
Net tangible assets: 3933787.417218543
Owner earnings: -3681635.0993377483
Return on net tangible assets (%): -93.59008784315336
Buffett classification: The Gruesome
Stock price: 0.006622516556291391
Shares outstanding: 3040003147
Book value: 3831707.947019867
P/B ratio: 5.254176845039449
Market cap (USD): 20132471.172185432
Debt to equity: 0
Current ratio: 1.1513573773891932
Quick ratio: 1.1513573773891932
Free cash flow (dilution-adjusted): -2931724.5033112583
Buyback yield (%): 0
Retained earnings: -30721118.54304636
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -76.20814975597337
Rule of 40 score: 0
Financial ratios for EVR.AX — annual report dated 2024-06-30
Operating income: -2225203.3333333335
Net income: -2257586.6666666665
Capital expenditures: 226164.66666666666
Depreciation & amortization: 3680
Net tangible assets: 4789186
Owner earnings: -2480071.333333333
Return on net tangible assets (%): -51.78481966107253
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 3040003147
Book value: 3705321.3333333335
P/B ratio: 5.46961675478618
Market cap (USD): 20266687.64666667
Debt to equity: 0.45559053627737545
Current ratio: 0.2003217861532897
Quick ratio: 0.2003217861532897
Interest coverage ratio: -6.767485381539784
Free cash flow (dilution-adjusted): -3988030
Buyback yield (%): 1.9318105001948538
Retained earnings: -33183512.666666668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -54.92328473594722
Rule of 40 score: 0
Financial ratios for G88.AX — annual report dated 2021-06-30
Operating income: -924967.6691729323
Net income: -924641.3533834586
Capital expenditures: 949484.962406015
Net tangible assets: 2053863.909774436
Owner earnings: -1874126.3157894737
Return on net tangible assets (%): -91.24880703489737
Buffett classification: The Gruesome
Stock price: 0.03759398496240601
Shares outstanding: 746051700
Book value: 2053863.909774436
P/B ratio: 13.655752096085905
Market cap (USD): 28047056.390977442
Debt to equity: 0
Current ratio: 4.8964734442756015
Quick ratio: 4.8964734442756015
Free cash flow (dilution-adjusted): -1537514.2857142857
Buyback yield (%): 0.44544366027180154
Retained earnings: -5829571.428571428
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -45.035489682201785
Rule of 40 score: 0
Financial ratios for G88.AX — annual report dated 2022-06-30
Operating income: -709000
Net income: -708737.2413793104
Capital expenditures: 773746.8965517242
Net tangible assets: 3320993.103448276
Owner earnings: -1482484.1379310344
Return on net tangible assets (%): -44.639783695778576
Buffett classification: The Gruesome
Stock price: 0.020689655172413793
Shares outstanding: 746051700
Book value: 3320993.103448276
P/B ratio: 4.647872468559466
Market cap (USD): 15435552.413793104
Debt to equity: 0
Current ratio: 6.321591680841387
Quick ratio: 6.321591680841387
Free cash flow (dilution-adjusted): -1356144.8275862068
Buyback yield (%): 1.0784015817313106
Retained earnings: -6016359.310344827
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.34903560214643
Rule of 40 score: 0
Financial ratios for G88.AX — annual report dated 2023-06-30
Operating income: -924146.357615894
Net income: -918268.2119205298
Capital expenditures: 1016607.2847682119
Net tangible assets: 4360577.483443708
Owner earnings: -1934875.4966887417
Return on net tangible assets (%): -44.37200127815868
Buffett classification: The Gruesome
Stock price: 0.033112582781456956
Shares outstanding: 746051700
Book value: 4360577.483443709
P/B ratio: 5.665235572419474
Market cap (USD): 24703698.67549669
Debt to equity: 0
Current ratio: 6.072772885778079
Quick ratio: 6.072772885778079
Free cash flow (dilution-adjusted): -1662790.0662251655
Buyback yield (%): 0.9156550410648483
Retained earnings: -6574970.860927152
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.19321032878566
Rule of 40 score: 0
Financial ratios for G88.AX — annual report dated 2024-06-30
Operating income: -1082654.6666666667
Net income: -1033545.3333333334
Capital expenditures: 1000831.3333333334
Net tangible assets: 4155896.6666666665
Owner earnings: -2034376.6666666667
Return on net tangible assets (%): -48.951570018183006
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 746051700
Book value: 4155896.6666666665
P/B ratio: 1.1967761469847262
Market cap (USD): 4973678
Debt to equity: 0
Current ratio: 6.66906439854192
Quick ratio: 6.66906439854192
Free cash flow (dilution-adjusted): -1801680.6666666667
Buyback yield (%): 0.5576557227870401
Retained earnings: -7379532
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -26.051048750811102
Rule of 40 score: 0
Financial ratios for GGT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.11
Shares outstanding: 41809633
Market cap (USD): 171837591.63000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GGT — annual report dated 2022-12-31
Total revenue: -90917037
Net income: -91646380
Capital expenditures: 0
Net tangible assets: 193907454
Owner earnings: -91646380
Return on net tangible assets (%): -47.2629484372478
Buffett classification: The Gruesome
Stock price: 2.85
Shares outstanding: 41809633
Book value: 193907454
P/B ratio: 0.6145068257664814
Market cap (USD): 119157454.05
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: -25268026
Receivables turnover: -128.86437333900287
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GGT — annual report dated 2023-12-31
Total revenue: 24011430
Net income: 23283073
Capital expenditures: 0
Net tangible assets: 184477101
Owner earnings: 23283073
Return on net tangible assets (%): 12.62111821672653
Buffett classification: The Gruesome
Stock price: 3.49
P/E ratio: 6.267025798957037
Shares outstanding: 41809633
Book value: 184477101
P/B ratio: 0.7909687347591179
Market cap (USD): 145915619.17000002
Debt to equity: 0.00037745064087927097
COGS to revenue (%): 0
SG&A to revenue (%): 2.3415931495958384
Buyback yield (%): 0
Retained earnings: -3783743
Receivables turnover: 3.713239609386127
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GGT — annual report dated 2024-12-31
Total revenue: 16714681
Net income: 15984519
Capital expenditures: 0
Net tangible assets: 189374235
Owner earnings: 15984519
Return on net tangible assets (%): 8.440704196112
Buffett classification: The Gruesome
Stock price: 3.28
P/E ratio: 8.579275750493336
Shares outstanding: 41809633
Book value: 189374235
P/B ratio: 0.7241512882679104
Market cap (USD): 137135596.23999998
Debt to equity: 0
COGS to revenue (%): 0
SG&A to revenue (%): 3.3170959110736247
Buyback yield (%): 0
Retained earnings: 8688685
Receivables turnover: 41.917590175322445
Capitalized R&D asset: 0
Revenue growth (%): -30.388648239609218
Rule of 40 score: -30.388648239609218
Financial ratios for GGT — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 189374235
Buffett classification: The Gruesome
Stock price: 3.28
Shares outstanding: 41809633
Book value: 189374235
P/B ratio: 0.7241512882679104
Market cap (USD): 137135596.23999998
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 8688685
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GGT — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 207743263
Buffett classification: The Gruesome
Stock price: 3.35
Shares outstanding: 41809633
Book value: 207743263
P/B ratio: 0.6742084846814022
Market cap (USD): 140062270.55
Debt to equity: 2.6200608969928425e-05
Buyback yield (%): 0
Retained earnings: 32738236
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GOODYEAR.NS — annual report dated 2022-03-31
Total revenue: 320377159.4355796
Gross profit: 90220229.46063563
Operating income: 16232361.86205987
Net income: 13568508.50586839
Capital expenditures: 9684821.31082685
Operating cash flow: 11778979.295793222
Depreciation & amortization: 6945799.815376501
Net tangible assets: 94247659.2377687
Owner earnings: 10829487.010418043
Return on net tangible assets (%): 11.490457267588292
Capex to operating income (%): 59.6636607360468
Buffett classification: The Good
Stock price: 10.458789397336147
P/E ratio: 17.779974765895616
Shares outstanding: 23066507
Book value: 94267440.32704735
P/B ratio: 2.559184146808332
Market cap (USD): 241247738.84518003
Debt to equity: 0.023306240644628794
Current ratio: 1.573481384715872
Quick ratio: 1.0819562377531027
Effective tax rate (%): 25.684362585771037
Interest coverage ratio: 29.876213592233007
COGS to revenue (%): 71.83936906751406
SG&A to revenue (%): 3.8626503445266773
Free cash flow (dilution-adjusted): 2094157.9849663721
Buyback yield (%): 0
Retained earnings: 74073585.65211658
Inventory turnover: 5.798079798013355
Receivables turnover: 9.73169363883993
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.355084306612987
FCF margin (%): 0.6536539585580097
Rule of 40 score: 0.6536539585580097
Financial ratios for GOODYEAR.NS — annual report dated 2023-03-31
Total revenue: 355390986.60170525
Gross profit: 88498172.95980512
Operating income: 18947624.84774665
Net income: 14964677.222898904
Capital expenditures: 13522533.495736906
Operating cash flow: 13665042.630937882
Depreciation & amortization: 6576126.674786846
Net tangible assets: 73774665.04263094
Owner earnings: 8018270.401948845
Return on net tangible assets (%): 10.868596146543615
Capex to operating income (%): 71.36796091540242
Buffett classification: The Good
Stock price: 12.779537149817298
P/E ratio: 19.698338877095882
Shares outstanding: 23066507
Book value: 73789281.36419001
P/B ratio: 3.9948794414750504
Market cap (USD): 294779283.12302077
Debt to equity: 0.01569799111932784
Current ratio: 1.2808203704898988
Quick ratio: 0.8187891305750985
Effective tax rate (%): 25.710484943765877
Interest coverage ratio: 40.19638242894057
COGS to revenue (%): 75.09836312787893
SG&A to revenue (%): 3.417690282956789
Free cash flow (dilution-adjusted): 142509.13520097444
Buyback yield (%): 0
Retained earnings: 55137637.02801462
Inventory turnover: 7.652673488631999
Receivables turnover: 9.075458786936236
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.24676964321898
FCF margin (%): 0.0400992542224172
Revenue growth (%): 10.928939886916664
Rule of 40 score: 10.969039141139081
Financial ratios for GOODYEAR.NS — annual report dated 2024-03-31
Total revenue: 301604508.9339249
Gross profit: 80563616.74061638
Operating income: 13992085.381940281
Net income: 11374265.499460367
Capital expenditures: 6576328.096894112
Operating cash flow: 16173402.086581124
Depreciation & amortization: 6630291.401846744
Net tangible assets: 69715793.2605828
Owner earnings: 11428228.804413002
Return on net tangible assets (%): 16.39259666987753
Capex to operating income (%): 47.00034281796366
Buffett classification: The Good
Stock price: 15.286845895343257
P/E ratio: 31.001046869319666
Shares outstanding: 23066507
Book value: 69726585.92157333
P/B ratio: 5.057097421196956
Market cap (USD): 352614137.8528565
Debt to equity: 0.011849686129503828
Current ratio: 1.2743082023009698
Quick ratio: 0.7345375901863112
Effective tax rate (%): 25.915800984144344
Interest coverage ratio: 27.518867924528305
COGS to revenue (%): 73.28832482465766
SG&A to revenue (%): 3.816180797429903
Free cash flow (dilution-adjusted): 9597073.989687013
Buyback yield (%): 0
Retained earnings: 51363472.83846984
Inventory turnover: 6.053597819304411
Receivables turnover: 9.406036127005498
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.96372383305162
FCF margin (%): 3.1820061389697347
Revenue growth (%): -15.134451827856868
Rule of 40 score: -11.952445688887133
Financial ratios for GOODYEAR.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 70170807.45341615
Buffett classification: The Gruesome
Stock price: 15.286845895343257
Shares outstanding: 23066507
Book value: 70180363.11514573
P/B ratio: 5.024398880272512
Market cap (USD): 352614137.8528565
Debt to equity: 0.009258786486256488
Current ratio: 1.270688096587862
Quick ratio: 0.8549803116429434
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GOODYEAR.NS — quarterly report dated 2024-12-31
Total revenue: 73635621.8673505
Gross profit: 19351905.81652873
Operating income: 1172630.842755566
Net income: 1105023.8955589228
Capital expenditures: 0
Depreciation & amortization: 1605082.1774099544
Owner earnings: 2710106.072968877
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.286845895343257
P/E ratio: 79.77522913079264
Shares outstanding: 23066507
Market cap (USD): 352614137.8528565
Effective tax rate (%): 28.560663149962316
Interest coverage ratio: 6.706666666666667
COGS to revenue (%): 73.71936934084722
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for GOODYEAR.NS — annual report dated 2025-03-31
Total revenue: 301478840.30862755
Gross profit: 77127659.57446808
Operating income: 7359130.231470657
Net income: 6443768.996960486
Capital expenditures: 2811550.151975684
Operating cash flow: 15337853.635725975
Depreciation & amortization: 6400514.379237783
Net tangible assets: 70480476.96983866
Owner earnings: 10032733.224222586
Return on net tangible assets (%): 14.234769195043873
Capex to operating income (%): 38.20492454328833
Buffett classification: The Good
Stock price: 15.286845895343257
P/E ratio: 54.721722336598965
Shares outstanding: 23066507
Book value: 70487491.23217207
P/B ratio: 5.002506568029414
Market cap (USD): 352614137.8528565
Debt to equity: 0.04834563396633221
Current ratio: 1.35160535174205
Quick ratio: 0.8629769492336347
Effective tax rate (%): 26.191751472951257
Interest coverage ratio: 13.4508547008547
COGS to revenue (%): 74.41689124997576
SG&A to revenue (%): 4.052969346801868
Free cash flow (dilution-adjusted): 12526303.483750291
Buyback yield (%): 0
Retained earnings: 52585924.71358428
Inventory turnover: 6.711078472513638
Receivables turnover: 9.125119422525742
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.559895516948124
FCF margin (%): 4.154952789033872
Revenue growth (%): -0.04166669316104252
Rule of 40 score: 4.113286095872829
Financial ratios for GOODYEAR.NS — quarterly report dated 2025-03-31
Total revenue: 70458265.1391162
Gross profit: 19108019.639934532
Operating income: 479307.9261164367
Net income: 569324.292728548
Capital expenditures: 0
Depreciation & amortization: 1547813.88823942
Net tangible assets: 70480476.96983866
Owner earnings: 2117138.180967968
Return on net tangible assets (%): 3.0038647182736486
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.286845895343257
P/E ratio: 154.83887757665988
Shares outstanding: 23066507
Book value: 70487491.23217207
P/B ratio: 5.002506568029414
Market cap (USD): 352614137.8528565
Debt to equity: 0.04834563396633221
Current ratio: 1.35160535174205
Quick ratio: 0.8629769492336347
Effective tax rate (%): 28.487518355359764
Interest coverage ratio: 3.106060606060606
COGS to revenue (%): 72.88037166085947
Buyback yield (%): 0
Retained earnings: 52585924.71358428
Inventory turnover: 1.5360539935655335
Receivables turnover: 2.132620926364955
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.6226460940347468
Revenue growth (%): -4.314972356664679
Rule of 40 score: -4.314972356664679
Financial ratios for GOODYEAR.NS — quarterly report dated 2025-06-30
Total revenue: 76786800.84249942
Gross profit: 21157266.55745378
Operating income: 1819564.7086356191
Net income: 1651064.8256494268
Capital expenditures: 0
Depreciation & amortization: 1483735.0807395275
Owner earnings: 3134799.9063889543
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.286845895343257
P/E ratio: 106.03619351191594
Shares outstanding: 23066507
Market cap (USD): 352614137.8528565
Effective tax rate (%): 25.580168776371302
Interest coverage ratio: 12.34126984126984
COGS to revenue (%): 72.44674042241931
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 8.981963565080484
Rule of 40 score: 8.981963565080484
Financial ratios for GOODYEAR.NS — quarterly report dated 2025-09-30
Total revenue: 67244644.8703495
Gross profit: 19444193.912063133
Operating income: 1609921.0822998872
Net income: 1473506.2006764375
Capital expenditures: 0
Depreciation & amortization: 1417136.4148816234
Net tangible assets: 64795941.37542277
Owner earnings: 2890642.615558061
Return on net tangible assets (%): 4.46114764937189
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.286845895343257
P/E ratio: 73.47782325218154
Shares outstanding: 23066507
Book value: 64799323.56257045
P/B ratio: 5.441633005819437
Market cap (USD): 352614137.8528565
Debt to equity: 0.04834977469248569
Current ratio: 1.3742282639478902
Quick ratio: 0.9116964032851884
Effective tax rate (%): 25.399543378995432
Interest coverage ratio: 10.984615384615385
COGS to revenue (%): 71.08439794789257
Buyback yield (%): 0
Inventory turnover: 1.7307127112417342
Receivables turnover: 2.0935032115404866
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.268791407826377
Revenue growth (%): -12.426817978420841
Rule of 40 score: -12.426817978420841
Financial ratios for GOODYEAR.NS — quarterly report dated 2025-12-31
Total revenue: 67607218.4471427
Gross profit: 20972485.240057927
Operating income: 3335189.929820653
Net income: 2743678.2889606776
Capital expenditures: 0
Depreciation & amortization: 1362370.5023950096
Owner earnings: 4106048.791355687
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.286845895343257
P/E ratio: 54.77438540102048
Shares outstanding: 23066507
Market cap (USD): 352614137.8528565
Effective tax rate (%): 26.146926536731634
Interest coverage ratio: 24.95
COGS to revenue (%): 68.97892603516172
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.5391858005827316
Rule of 40 score: 0.5391858005827316
Financial ratios for HCWB — annual report dated 2021-12-31
Capital expenditures: 47263
Buffett classification: The Gruesome
Stock price: 556.8
Shares outstanding: 1596848
Market cap (USD): 889124966.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCWB — annual report dated 2022-12-31
Total revenue: 6722090
Gross profit: 2586378
Operating income: -15078778
Net income: -14900703
Capital expenditures: 10275128
Operating cash flow: -10386110
Depreciation & amortization: 717854
Net tangible assets: 37428506
Owner earnings: -24457977
Return on net tangible assets (%): -65.34585430687508
Buffett classification: The Gruesome
Stock price: 459.6
Shares outstanding: 1596848
Book value: 37428506
P/B ratio: 19.608352542845285
Market cap (USD): 733911340.8000001
Debt to equity: 0.17125698257900007
Current ratio: 11.524146104777945
Quick ratio: 11.524146104777945
Interest coverage ratio: -119.04924996052424
COGS to revenue (%): 61.524198575145526
R&D to revenue (%): 138.92055893330794
SG&A to revenue (%): 118.8370432410158
Free cash flow (dilution-adjusted): -21781429
Buyback yield (%): 0
Retained earnings: -45538046
Receivables turnover: 16.09329774117478
Capitalized R&D asset: 9338365
ROCI (R&D-adjusted, %): -16.644159429435724
FCF margin (%): -324.0276312872931
Rule of 40 score: -324.0276312872931
Financial ratios for HCWB — annual report dated 2023-12-31
Total revenue: 2841794
Gross profit: 560360
Operating income: -25717160
Net income: -24994277
Capital expenditures: 6202600
Operating cash flow: -22514121
Depreciation & amortization: 1135184
Net tangible assets: 13461717
Owner earnings: -30061693
Return on net tangible assets (%): -223.312471952872
Buffett classification: The Gruesome
Stock price: 294
Shares outstanding: 1596848
Book value: 13461717
P/B ratio: 34.874697781865414
Market cap (USD): 469473312
Debt to equity: 0.4683145545252511
Current ratio: 0.7321058001457539
Quick ratio: 0.7321058001457539
Interest coverage ratio: -90.85987238643028
COGS to revenue (%): 80.28147008544603
R&D to revenue (%): 270.12218338134295
SG&A to revenue (%): 460.42890512120164
Free cash flow (dilution-adjusted): -29720470
Buyback yield (%): 0
Retained earnings: -70532323
Receivables turnover: 1.8504190441586787
Capitalized R&D asset: 13933020.55
ROCI (R&D-adjusted, %): -70.365189606429
Rosenberg metric: -0.21695639440094705
FCF margin (%): -1045.8347790163539
Revenue growth (%): -57.724546978692636
Rule of 40 score: -1103.5593259950465
Financial ratios for HCWB — quarterly report dated 2024-09-30
Capital expenditures: 37063
Buffett classification: The Gruesome
Stock price: 129.36
Shares outstanding: 1596848
Market cap (USD): 206568257.28000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCWB — quarterly report dated 2024-12-31
Capital expenditures: 113412
Buffett classification: The Gruesome
Stock price: 107.04
Shares outstanding: 1596848
Market cap (USD): 170926609.92000002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HCWB — annual report dated 2024-12-31
Total revenue: 2566792
Gross profit: 959403
Operating income: -27629216
Net income: -30023814
Capital expenditures: 261617
Operating cash flow: -14227428
Depreciation & amortization: 1184389
Net tangible assets: -6770172
Owner earnings: -29101042
Buffett classification: The Gruesome
Stock price: 107.04
Shares outstanding: 1596848
Book value: -6770172
Market cap (USD): 170926609.92000002
Debt to equity: -2.022481703566763
Current ratio: 0.19232860095815282
Quick ratio: 0.19232860095815282
Interest coverage ratio: -23.38312169724134
COGS to revenue (%): 62.62248752528448
R&D to revenue (%): 248.90968960476732
SG&A to revenue (%): 854.9667444810486
Free cash flow (dilution-adjusted): -15498056
Buyback yield (%): 0
Retained earnings: -100556137
Receivables turnover: 4.4087729151959545
Capitalized R&D asset: 14613786.170000002
ROCI (R&D-adjusted, %): -190.7925417474391
Rosenberg metric: 0.05198365987017731
FCF margin (%): -603.7908798219723
Revenue growth (%): -9.677056113145428
Rule of 40 score: -613.4679359351178
Financial ratios for HCWB — quarterly report dated 2025-03-31
Total revenue: 5065
Gross profit: 1013
Operating income: -1692743
Net income: -2196875
Capital expenditures: 0
Operating cash flow: -3513856
Depreciation & amortization: 419010
Net tangible assets: -8562048
Owner earnings: -1777865
Buffett classification: The Gruesome
Stock price: 67.68
Shares outstanding: 1596848
Book value: -8562048
Market cap (USD): 108074672.64000002
Debt to equity: -1.6280803377883422
Current ratio: 0.06980700454533899
Quick ratio: 0.06980700454533899
Interest coverage ratio: -3.2006122360228484
COGS to revenue (%): 80
R&D to revenue (%): 29194.689042448175
SG&A to revenue (%): 3036.6831194471865
Free cash flow (dilution-adjusted): -3789498
Buyback yield (%): 0
Retained earnings: -102753012
Receivables turnover: 0.057890345513355354
Capitalized R&D asset: 1478711
ROCI (R&D-adjusted, %): -113.65031850171563
FCF margin (%): -74817.33464955578
Rule of 40 score: -74817.33464955578
Financial ratios for HCWB — quarterly report dated 2025-06-30
Total revenue: 6550
Gross profit: 1310
Operating income: -3361829
Net income: -1927730
Capital expenditures: 0
Operating cash flow: -3282303
Depreciation & amortization: 291916
Net tangible assets: -51972
Owner earnings: -1635814
Buffett classification: The Gruesome
Stock price: 23.79
Shares outstanding: 1596848
Book value: -51972
Market cap (USD): 37989013.92
Debt to equity: -130.61561994920342
Current ratio: 0.10791604337628023
Quick ratio: 0.10791604337628023
Interest coverage ratio: -10.157749228008049
COGS to revenue (%): 80
R&D to revenue (%): 18730.137404580153
SG&A to revenue (%): 31712.290076335878
Free cash flow (dilution-adjusted): -3560610
Buyback yield (%): 0
Retained earnings: -104680742
Receivables turnover: 0.3030863911896719
Capitalized R&D asset: 2217560.37
ROCI (R&D-adjusted, %): -70.93628470136137
Rosenberg metric: 0.00020085060569644778
FCF margin (%): -54360.45801526717
Revenue growth (%): 29.318854886475815
Rule of 40 score: -54331.13916038069
Financial ratios for HCWB — quarterly report dated 2025-09-30
Total revenue: 15606
Gross profit: 3121
Operating income: -3276624
Net income: -4554336
Capital expenditures: 0
Operating cash flow: -3239941
Depreciation & amortization: 173905
Net tangible assets: -2107197
Owner earnings: -4380431
Buffett classification: The Gruesome
Stock price: 22.2
Shares outstanding: 1596848
Book value: -2107197
Market cap (USD): 35450025.6
Debt to equity: -3.2305622113167396
Current ratio: 0.05914239823774993
Quick ratio: 0.05914239823774993
Interest coverage ratio: -22.982240552142077
COGS to revenue (%): 80.00128155837498
R&D to revenue (%): 8998.122516980648
SG&A to revenue (%): 11643.259002947585
Free cash flow (dilution-adjusted): -3445433
Buyback yield (%): 0
Retained earnings: -109235078
Receivables turnover: 0.5088857729807285
Capitalized R&D asset: 2714193.71
ROCI (R&D-adjusted, %): -249.49866850729433
Rosenberg metric: 0.001476169360886321
FCF margin (%): -22077.617582980904
Revenue growth (%): 138.25954198473283
Rule of 40 score: -21939.358040996172
Financial ratios for HCWB — annual report dated 2025-12-31
Total revenue: 54232
Gross profit: 10846
Operating income: -11257288
Net income: -7959709
Capital expenditures: 0
Operating cash flow: -13391617
Depreciation & amortization: 1041771
Net tangible assets: 2764769
Owner earnings: -6917938
Return on net tangible assets (%): -250.2175769476582
Buffett classification: The Gruesome
Stock price: 5.83
Shares outstanding: 1596848
Book value: 2764769
P/B ratio: 3.3672338774053094
Market cap (USD): 9309623.84
Debt to equity: 2.462851326819709
Current ratio: 0.10845511686932258
Quick ratio: 0.10845511686932258
Interest coverage ratio: -9.003863956111985
COGS to revenue (%): 80.00073757191326
R&D to revenue (%): 10036.2959138516
SG&A to revenue (%): 10304.331391060628
Free cash flow (dilution-adjusted): -14160240
Buyback yield (%): 0
Retained earnings: -108515846
Receivables turnover: 1.6855322455322455
Capitalized R&D asset: 12256694.260000002
ROCI (R&D-adjusted, %): -78.38322408381312
Rosenberg metric: -0.1484673486937067
FCF margin (%): -26110.48827260658
Revenue growth (%): -97.88716810711581
Rule of 40 score: -26208.375440713695
Financial ratios for HCWB — quarterly report dated 2025-12-31
Total revenue: 27010
Gross profit: 5401
Operating income: -2947409
Net income: 719232
Capital expenditures: 0
Operating cash flow: -3355517
Depreciation & amortization: 156940
Net tangible assets: 2764769
Owner earnings: 876172
Return on net tangible assets (%): 31.690604169823956
Buffett classification: The Gruesome
Stock price: 5.83
P/E ratio: 3.235959968410749
Shares outstanding: 1596848
Book value: 2764769
P/B ratio: 3.3672338774053094
Market cap (USD): 9309623.84
Debt to equity: 2.462851326819709
Current ratio: 0.10845511686932258
Quick ratio: 0.10845511686932258
Interest coverage ratio: -13.010488167704743
COGS to revenue (%): 80.00370233246944
R&D to revenue (%): 4935.586819696409
SG&A to revenue (%): 5781.384672343576
Free cash flow (dilution-adjusted): -3364699
Buyback yield (%): 0
Retained earnings: -108515846
Receivables turnover: 0.8394716394716395
Capitalized R&D asset: 2678799.41
ROCI (R&D-adjusted, %): -47.84306452427569
Rosenberg metric: 0.0016236459825087752
FCF margin (%): -12457.234357645317
Revenue growth (%): 73.07445854158658
Rule of 40 score: -12384.15989910373
Financial ratios for HEPS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.91
Shares outstanding: 317225200
Market cap (USD): 605900132
Buyback yield (%): 0
Retained earnings: -130670955.6057186
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEPS — annual report dated 2022-12-31
Total revenue: 2044311443.8502674
Gross profit: 444255294.11764705
Operating income: -349306363.6363636
Net income: -369878983.95721924
Capital expenditures: 107493529.41176471
Operating cash flow: 54571925.13368984
Depreciation & amortization: 65232299.46524064
Net tangible assets: 105461283.4224599
Owner earnings: -412140213.90374327
Return on net tangible assets (%): -390.79764680350036
Buffett classification: The Gruesome
Stock price: 0.66
Shares outstanding: 317225200
Book value: 179989197.86096263
P/B ratio: 1.163228874222398
Market cap (USD): 209368632
Debt to equity: 0.14017775279443387
Current ratio: 1.0816444410526695
Quick ratio: 0.8507763359775071
Interest coverage ratio: -8.071587446339999
COGS to revenue (%): 78.26870776201625
SG&A to revenue (%): 33.46842669513818
Free cash flow (dilution-adjusted): -72335080.21390374
Buyback yield (%): 0
Inventory turnover: 10.154614876328123
Receivables turnover: 22.69402157523431
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -170.75409872063085
FCF margin (%): -3.5383591101788023
Rule of 40 score: -3.5383591101788023
Financial ratios for HEPS — annual report dated 2023-12-31
Total revenue: 2276380589.4308944
Gross profit: 689462635.501355
Operating income: -41113177.506775066
Net income: 4835501.35501355
Capital expenditures: 73374762.87262873
Operating cash flow: 321313279.13279134
Depreciation & amortization: 75165514.90514906
Net tangible assets: 70878353.65853658
Owner earnings: 6626253.387533873
Return on net tangible assets (%): 9.348768764376919
Buffett classification: The Gruesome
Stock price: 1.8
P/E ratio: 118.08607175923332
Shares outstanding: 317225200
Book value: 161534993.2249323
P/B ratio: 3.5348709812052506
Market cap (USD): 571005360
Debt to equity: 0.14008601842964458
Current ratio: 1.0716802347937697
Quick ratio: 0.7811217265852863
Effective tax rate (%): 0
Interest coverage ratio: -0.4661499432513246
COGS to revenue (%): 69.7123302358801
SG&A to revenue (%): 27.24549881913735
Free cash flow (dilution-adjusted): 240643055.55555558
Buyback yield (%): 0.5384051899661558
Retained earnings: -594102235.7723577
Inventory turnover: 8.183247388463823
Receivables turnover: 16.949864549912224
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.364935277322665
FCF margin (%): 10.571301506999648
Revenue growth (%): 11.351946704536696
Rule of 40 score: 21.923248211536343
Financial ratios for HEPS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.26
Shares outstanding: 317225200
Market cap (USD): 716928951.9999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEPS — annual report dated 2024-12-31
Total revenue: 2114686264.5143018
Gross profit: 792880657.0376663
Operating income: 16049447.748513168
Net income: -59492976.49391107
Capital expenditures: 73981648.25828376
Operating cash flow: 211210025.48853016
Depreciation & amortization: 75923477.76833758
Net tangible assets: 9728320.589068253
Owner earnings: -57551146.98385726
Return on net tangible assets (%): -591.583577627239
Capex to operating income (%): 460.9607097860266
Buffett classification: The Gruesome
Stock price: 3.03
Shares outstanding: 317225200
Book value: 123125630.13310671
P/B ratio: 7.806598471503368
Market cap (USD): 961192355.9999999
Debt to equity: 0.8055003650318365
Current ratio: 0.9661201626859066
Quick ratio: 0.6880948820619198
Interest coverage ratio: 0.15106230301065823
COGS to revenue (%): 62.50599106152638
SG&A to revenue (%): 30.672564990730088
Free cash flow (dilution-adjusted): 130009742.28263946
Buyback yield (%): 0
Retained earnings: -710431888.9832908
Inventory turnover: 5.941474517691539
Receivables turnover: 11.15222584290371
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.496946999318281
FCF margin (%): 6.147944707651464
Revenue growth (%): -7.103132299903195
Rule of 40 score: -0.9551875922517308
Financial ratios for HEPS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.03
Shares outstanding: 317225200
Market cap (USD): 961192355.9999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HEPS — quarterly report dated 2025-03-31
Total revenue: 495731121.64297
Gross profit: 183392890.9952607
Operating income: -13531727.224855188
Net income: -12235150.078988943
Capital expenditures: 20488362.295945235
Operating cash flow: -11620063.19115324
Depreciation & amortization: 22649605.05529226
Net tangible assets: -2500026.329647183
Owner earnings: -10073907.319641918
Buffett classification: The Gruesome
Stock price: 2.85
Shares outstanding: 317225200
Book value: 88038204.31806207
P/B ratio: 10.269312362775159
Market cap (USD): 904091820
Debt to equity: 0.8218540529014201
Current ratio: 0.9406790047799976
Quick ratio: 0.6169999003589481
Interest coverage ratio: -0.22101575172921545
COGS to revenue (%): 63.0055723781365
SG&A to revenue (%): 31.17866027104078
Free cash flow (dilution-adjusted): -33638967.87783044
Buyback yield (%): 0
Retained earnings: -564730753.0279095
Inventory turnover: 1.6937721571618045
Receivables turnover: 3.6601510026994486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.850034612610058
FCF margin (%): -6.785728474408255
Rule of 40 score: -6.785728474408255
Financial ratios for HEPS — quarterly report dated 2025-06-30
Total revenue: 419748583.60491353
Gross profit: 158822060.6668338
Operating income: 853672.5996490348
Net income: -18145475.056405112
Capital expenditures: 8007395.3371772375
Operating cash flow: 99178791.67711206
Depreciation & amortization: 17683830.53396841
Net tangible assets: -20128628.729004763
Owner earnings: -8469039.859613938
Capex to operating income (%): 937.9937156785012
Buffett classification: The Gruesome
Stock price: 2.7
Shares outstanding: 317225200
Book value: 71287641.01278508
P/B ratio: 12.014818106358572
Market cap (USD): 856508040
Debt to equity: 0.8562593892949387
Current ratio: 0.9210292597189829
Quick ratio: 0.624818745369316
Interest coverage ratio: 0.014453336389276187
COGS to revenue (%): 63.13857254736701
SG&A to revenue (%): 28.113201022637014
Free cash flow (dilution-adjusted): 90723940.83730258
Buyback yield (%): 0
Retained earnings: -588133617.447982
Inventory turnover: 1.4285856367373133
Receivables turnover: 2.8972451915523316
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8127124232376616
FCF margin (%): 21.613876587299238
Revenue growth (%): -15.327368954814135
Rule of 40 score: 6.286507632485103
Financial ratios for HEPS — quarterly report dated 2025-09-30
Total revenue: 479072823.4728235
Gross profit: 178203415.1034151
Operating income: -14202645.502645504
Net income: -31862650.312650315
Capital expenditures: 14583140.933140934
Operating cash flow: 81219600.76960078
Depreciation & amortization: 20912481.962481964
Net tangible assets: -73957190.95719096
Owner earnings: -25533309.283309285
Buffett classification: The Gruesome
Stock price: 2.69
Shares outstanding: 317225200
Book value: 20736291.486291528
P/B ratio: 41.151803279970686
Market cap (USD): 853335788
Debt to equity: 3.2223146199033823
Current ratio: 0.8462707738938455
Quick ratio: 0.531544268324446
Interest coverage ratio: -0.20825573575551798
COGS to revenue (%): 62.802437046708384
SG&A to revenue (%): 32.67579150202351
Free cash flow (dilution-adjusted): 63156445.40644541
Buyback yield (%): 0
Retained earnings: -624379990.3799905
Inventory turnover: 1.3042352315896788
Receivables turnover: 3.6001581768312874
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.540073167366746
FCF margin (%): 13.183057420920077
Revenue growth (%): 14.133279345082588
Rule of 40 score: 27.316336766002664
Financial ratios for HEPS — annual report dated 2025-12-31
Total revenue: 1970938766.0069847
Gross profit: 714095506.4027939
Operating income: -20992293.364377182
Net income: -132693271.24563445
Capital expenditures: 56053410.942956924
Operating cash flow: 262734458.6728754
Depreciation & amortization: 73840139.69732246
Net tangible assets: -43331338.766006984
Owner earnings: -114906542.49126892
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 317225200
Book value: 46835762.51455176
P/B ratio: 16.79738844340515
Market cap (USD): 786718496
Debt to equity: 1.2059200754028156
Current ratio: 0.8884975874118105
Quick ratio: 0.6270661924927738
Interest coverage ratio: -0.21434778050355927
COGS to revenue (%): 63.76876244361905
SG&A to revenue (%): 31.257628010833084
Free cash flow (dilution-adjusted): 201478975.55296856
Buyback yield (%): 0
Retained earnings: -426777415.59953433
Inventory turnover: 6.183957005329656
Receivables turnover: 13.298204207640435
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.35266911639823
FCF margin (%): 10.222487833102702
Revenue growth (%): -6.797580374899384
Rule of 40 score: 3.424907458203318
Financial ratios for HEPS — quarterly report dated 2025-12-31
Total revenue: 706311292.2002327
Gross profit: 241778649.59254947
Operating income: 6458905.704307334
Net income: -74307916.18160652
Capital expenditures: 16347543.65541327
Operating cash flow: 102268265.42491268
Depreciation & amortization: 20946961.583236318
Net tangible assets: -43331338.766006984
Owner earnings: -69708498.25378346
Capex to operating income (%): 253.10082549295268
Buffett classification: The Gruesome
Stock price: 2.48
Shares outstanding: 317225200
Book value: 46835762.51455176
P/B ratio: 16.79738844340515
Market cap (USD): 786718496
Debt to equity: 1.2059200754028156
Current ratio: 0.8884975874118105
Quick ratio: 0.6270661924927738
COGS to revenue (%): 65.76882569166013
SG&A to revenue (%): 32.2348676015054
Free cash flow (dilution-adjusted): 85823213.03841676
Buyback yield (%): 0
Retained earnings: -426777415.59953433
Inventory turnover: 2.2856071093246304
Receivables turnover: 4.765582756723656
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.800505468030323
FCF margin (%): 12.150904846936337
Revenue growth (%): 47.43297001907683
Rule of 40 score: 59.58387486601317
Financial ratios for INNOVACAP.NS — annual report dated 2024-03-31
Total revenue: 129147259.86329296
Gross profit: 39147020.02638206
Operating income: 16972058.999880083
Net income: 11313706.679457968
Capital expenditures: 34445976.735819645
Operating cash flow: 17548866.770595994
Depreciation & amortization: 1913538.7936203382
Net tangible assets: 97530159.49154575
Owner earnings: -21218731.26274134
Return on net tangible assets (%): -21.756071530448644
Capex to operating income (%): 202.9569702536565
Buffett classification: The Gruesome
Stock price: 5.376919385796546
P/E ratio: 27.19655359720466
Shares outstanding: 57224929
Book value: 99639525.1229164
P/B ratio: 3.0880700175091813
Market cap (USD): 307693830.09093094
Debt to equity: 0.29498828972167335
Current ratio: 2.1837871636764965
Quick ratio: 1.6413151976977636
Effective tax rate (%): 27.163029128612127
Interest coverage ratio: 6.676888238901732
COGS to revenue (%): 69.68807540491329
SG&A to revenue (%): 1.9793696881682588
Free cash flow (dilution-adjusted): -16910061.158412278
Buyback yield (%): 0
Retained earnings: 38937042.810888596
Inventory turnover: 5.211309854460616
Receivables turnover: 3.73311541554588
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.410081485692633
FCF margin (%): -13.09362751971059
Revenue growth (%): 14.57761995137608
Rule of 40 score: 1.4839924316654898
Financial ratios for INNOVACAP.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 104850931.67701863
Buffett classification: The Gruesome
Stock price: 9.207118967988533
Shares outstanding: 57224929
Book value: 106939560.43956044
P/B ratio: 4.926864549209314
Market cap (USD): 526876729.23769706
Debt to equity: 0.2917363827463034
Current ratio: 1.8888257551299767
Quick ratio: 1.3232304970492144
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for INNOVACAP.NS — quarterly report dated 2025-03-31
Total revenue: 36794599.01800327
Gross profit: 13644844.517184941
Operating income: 4428688.332943652
Net income: 3457212.999766191
Capital expenditures: 0
Depreciation & amortization: 1145896.6565349544
Net tangible assets: 110121463.64274023
Owner earnings: 4603109.656301145
Return on net tangible assets (%): 4.180029491103305
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.225813980627844
P/E ratio: 42.31526080749223
Shares outstanding: 57224929
Book value: 112160042.085574
P/B ratio: 5.217290116226699
Market cap (USD): 585171479.0086358
Debt to equity: 0.35242131419393236
Current ratio: 1.9918017926142482
Quick ratio: 1.4025875060905826
Effective tax rate (%): 24.77169240161787
Interest coverage ratio: 19.407274590163933
COGS to revenue (%): 62.91617552209594
Buyback yield (%): 0
Retained earnings: 52983282.67477203
Inventory turnover: 0.9520565398206686
Receivables turnover: 0.9490298361199475
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.0864353435668646
Rule of 40 score: 0
Financial ratios for INNOVACAP.NS — annual report dated 2025-03-31
Total revenue: 144309445.87327564
Gross profit: 46339256.488192655
Operating income: 19342997.42810381
Net income: 14993920.972644376
Capital expenditures: 20129296.235679213
Operating cash flow: 7463642.740238484
Depreciation & amortization: 2896773.4393266304
Net tangible assets: 110121463.64274023
Owner earnings: -2238601.8237082064
Return on net tangible assets (%): -2.0328478660352296
Capex to operating income (%): 104.06503082315967
Buffett classification: The Gruesome
Stock price: 10.225813980627844
P/E ratio: 39.02724844797105
Shares outstanding: 57224929
Book value: 112160042.085574
P/B ratio: 5.217290116226699
Market cap (USD): 585171479.0086358
Debt to equity: 0.35242131419393236
Current ratio: 1.9918017926142482
Quick ratio: 1.4025875060905826
Effective tax rate (%): 25.00233896243626
Interest coverage ratio: 73.73440285204991
COGS to revenue (%): 67.88896512783705
SG&A to revenue (%): 1.911176314764064
Free cash flow (dilution-adjusted): -12701776.946457796
Buyback yield (%): 0
Retained earnings: 52983282.67477203
Inventory turnover: 4.029120892329142
Receivables turnover: 3.7221215456286085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.480494996345943
FCF margin (%): -8.801764063048081
Revenue growth (%): 11.740230513626381
Rule of 40 score: 2.9384664505783
Financial ratios for INNOVACAP.NS — quarterly report dated 2025-06-30
Total revenue: 41135267.961619474
Gross profit: 15305874.093142992
Operating income: 4803884.858413293
Net income: 3629183.2436227477
Capital expenditures: 0
Depreciation & amortization: 1292417.5052656215
Owner earnings: 4921600.74888837
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.01883922302832
P/E ratio: 39.494241866105114
Shares outstanding: 57224929
Market cap (USD): 573327363.2002107
Effective tax rate (%): 27.326194437284716
Interest coverage ratio: 14.354545454545455
COGS to revenue (%): 62.79135921170159
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 11.79702744278407
Rule of 40 score: 11.79702744278407